Patent · US Expired

Use of 2-imidazolyl-substituted carbinols for the production of a medicament for the treatment or phophylaxis of diseases caused by ischemic conditions

US6291502A · kind A · utility

2Cited by

4References

9Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Andreas Weichert · Egelsbach, DE
Udo Albus · Florstadt, DE
Hans-Willi Jansen · Niedernhausen, DE

Key dates

Filing date	Oct 26, 2000
Grant date	Sep 18, 2001
Priority date	—
Expiry date	Oct 26, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of using 2-imidazolyl-substituted carbinols of the formula I for treating or preventing diseases caused by ischemic conditions: ##STR1## In these carbinols, R1, R2 and R3 have the meanings indicated in the specification and claims.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.